Glass House Brands (GLAS) Times Interest Earned (2020 - 2026)

Glass House Brands (GLAS) posted quarterly Times Interest Earned of -$11.08 for Q1 2026, down 229.91% quarter-over-quarter from $8.53 in Q4 2025.

Glass House Brands (GLAS) Times Interest Earned (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has reported Times Interest Earned for 7 consecutive years, with -$11.08 the latest figure, recorded in Q1 2026.

In Q1 2026, Times Interest Earned changed N/A year-over-year to -$11.08; the TTM figure through Mar 2026 stood at -$7.83 (changed N/A YoY), while the FY2025 annual figure was -$0.4, down 380.41% from the prior year.
Times Interest Earned eased to -$11.08 in Q1 2026 per GLAS's latest filing, from $8.53 in the prior quarter.
Across five years, Times Interest Earned topped out at $15.32 in Q1 2023 and bottomed at -$11.49 in Q1 2022.
Historically, Times Interest Earned has averaged $1.6 across 5 years, with a median of $1.61 in 2023.
On a YoY basis, Times Interest Earned climbed as much as 803.06% in 2022 and fell as far as 134.14% in 2022.
Glass House Brands' Times Interest Earned stood at $7.61 in 2022, then tumbled by 91.0% to $0.68 in 2023, then surged by 184.03% to $1.94 in 2024, then surged by 338.59% to $8.53 in 2025, then tumbled by 229.91% to -$11.08 in 2026.
Business Quant data shows GLAS's Times Interest Earned at -$11.08 in Q1 2026, $8.53 in Q4 2025, and -$6.26 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	-
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	114.07
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Glass House Brands	833.73 Mn	815.17 Mn	15.77 Mn	-4.77

Download Data